View Older Stories View More Recent Stories
-
Paycom Software (PAYC) PT Raised to $280 at KeyBanc
-
Dycom Industries (DY) PT Raised to $429 at KeyBanc
-
Good Purpose Investments Uplists to OTCQB Venture Market
-
Northwind Exploration Inc. Announces Entering into of a Definitive Agreement for Business Combination with 1510450 B.C. Ltd.
-
NSJ Gold Corp. (NSJ) (9PZ) Announces Closing of Financing for Exploration and Development on Its Antimony 2.0 Property, New Brunswick, Canada
-
Nickel 28 Files Fiscal Q2 2027 Financial Statements
-
naia Relief Inc. Announces Launch of naia 24/7 Mind Mentor Through Strategic Partnership with Felix Global
-
NexLiving Communities Inc. to Present at the Annual Smallcap Discoveries Conference in Vancouver
-
LatAm Lithium Announces Annual General and Special Meeting and Share Consolidation
-
Silver47 Achieves 80% Silver and 77% Gold Extraction from Belmont Tailings at the Hughes Project, Nevada
-
Excellon Drilling Confirms Grade and Width Below the 4090 Level at Mallay Silver Mine
-
Delta Extends I-Zone Gold Mineralization by More than 400 Metres, Thunder Bay, Ontario
-
Andean Precious Metals Announces Appointment of Brenda Dayton as Vice President, Investor Relations
-
Cordoba Minerals Announces Changes to Its Executive Team with Appointment of Interim Chief Financial Officer
-
Gold X2 Appoints Chief Geologist and Provides Update on 2026 Technical and Corporate Objectives
-
Amex Gold Mining Provides Update on Development Activities at the Perron Project - More than 75 m of Underground Decline Development Completed
-
Cantor on Rocket Lab USA, Inc. (RKLB): 'We remain bullish, and we view this as a good entry point'
-
JPMorgan Downgrades Shanghai Chicmax Cosmetic (2145:HK) to Neutral
-
JPMorgan Downgrades Guangdong Marubi Biotechnology Co Ltd (603983:CH) to Underweight
-
Oura files for 50M share IPO at $40-$44/sh
-
Truist Securities Reiterates Hold Rating on Lennar (LEN)
-
Truist: 'we continue to view Intuit as a "show me" story'
-
Truist Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
-
Truist Securities Reiterates Buy Rating on DigitalOcean (DOCN)
-
Corbyn Lichon returns as Baldwin Insurance chief accounting officer
-
Truist Securities Reiterates Buy Rating on Amer Sports Inc. (AS)
-
Methanex to redeem $300M of 2027 senior notes in October
-
Truist: 'MGM/CZR Nov rates are underperforming, but WYNN is meaningfully outperforming'
-
SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
-
Paramount, Warner Bros jump on report of settlement progress in merger fight
-
Crypto stocks rise premarket as Bitcoin hits over seven-month high
-
Fed's Goolsbee: Strong demand may be adding to inflation with energy, tariff and other supply shocks
-
Securitize Corp (SECZ) PT Raised to $13 at Rosenblatt
-
Bernstein sees cybersecurity as a major growth opportunity for Visa, Mastercard
-
Kolibri Global Energy completes fracking on three wells, renews buyback
-
Bernstein presents a 101 primer on equity tokenization, highlights winners
-
ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO
-
MS NOW, CNN and Politico sue Trump over White House ban
-
Bernstein on Otis Worldwide Corp (OTIS) CEO transition: 'Investors we’ve spoken with have been largely cautious on the news'
-
Bernstein favors cyclical and self-help trucking stocks
-
BlossomHill Therapeutics (BLSM) PT Raised to $40 at Guggenheim
-
Guggenheim Reiterates Neutral Rating on Snap Inc (SNAP)
-
Amrize Ltd (AMRZ:SW) (AMRZ) PT Lowered to CHF50 at Bernstein SocGen Group
-
Amrize Ltd (AMRZ) PT Lowered to $60 at Bernstein SocGen Group
-
Guggenheim Reiterates Buy Rating on Lowe's (LOW)
-
Cantor Fitzgerald Starts Securitize Corp (SECZ) at Overweight
-
Guggenheim Reiterates Neutral Rating on Accenture plc (ACN)
-
Clear Street Starts Nextnav Acquisition Corp. (NN) at Buy
-
Canaccord Reiterates Buy Rating on Barrick Gold Corp. (GOLD)
-
OS Therapies gets MHRA lead role in global OST-HER2 review
